You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
香港:或允許“未有收入、未有盈利”的科技公司主板IPO,正在檢視上市規則

財政司司長陳茂波在《財政預算案2022》提及,近年香港證券市場上市改革後IPO活動活躍,並預告考慮到一些從事先進技術且具規模的科技企業需要大量資金投入研發,但卻未有盈利和業績支持,證監會和港交所正檢視主板的上市規則,研究在充分顧及相關風險的情況下修訂上市條件配合有關集資需求。

在中概股上,陳茂波重申,中資企業海外市場上市須面對的風險和不確定因素增大,已有不少中概股選擇迴流。香港已爲此做好準備,包括容許沒有不同投票權架構並屬非創新產業的大中華公司在港第二上市,並給予雙重主要上市的發行人更大靈活性。這些措施將有利進一步吸納優質中概股在港上市,豐富市場選擇,增加市場流動性,提升香港全球融資平臺的競爭力。

他又提到,港股市場2018年改革,容許「同股不同權」架構的新興及創新企業上市;容許未有收入或盈利的生物科技公司在香港上市;便利合資格發行人在香港作第二上市。

截至上月底,共有70家公司循此新制度上市,融資金額逾5700多億元,佔同期總集資額近一半。

新經濟企業目前已佔香港股市總市值超過20%。其中,有48家爲醫療健康和生物科技公司,他們的融資額合共逾1100億元,讓香港成爲亞洲最大、全球第二大的生物科技融資中心,帶動香港生物科技生態圈快速全面發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account